Johns Hopkins e-mail
16 Aug
When I first read the e-mail, my hopes soared.
The message supposedly reported on a new “cancer update” from Johns Hopkins University, in which they disavowed chemotherapy and radiation therapy and even surgery as “treatments” for cancer, and suggested nutrition and other natural preventive measures as alternatives.
Too good to be true, I thought! Sure enough, it was. I’m really trying to be positive in outlook about these kinds of announcements because almost daily things are showing a decided trend toward the alternative health care universe. But, in this case, a check with Snopes revealed that the message is one of the urban legends that arise out of a widespread desire for such news to be true. The e-mail report generated so much interest that Johns Hopkins had to issue a disclaimer, stating: “Information falsely attributed to Johns Hopkins called, ‘CANCER UPDATE FROM JOHN HOPKINS’ describes properties of cancer cells and suggests ways of preventing cancer. Johns Hopkins did not publish the information, which often is an email attachment, nor do we endorse its contents.”
They even went on to claim: “Traditional therapies, such as surgery, chemotherapy, and radiation therapy, work. The evidence is the millions of cancer survivors in the United States today who are alive because of these therapies. We recognize that treatments don’t work in every patient, or sometimes work for awhile and then stop working, and there are some cancers that are more difficult to cure than others.”
It’s hard to imagine, in this day and age where so much is being discovered about the damage done by radiation and chemotherapy, that any “legitimate” medical institution could continue to praise these approaches so highly. At the very least, they might have conceded that the perceived “benefits” of such radical (some say barbaric) practices are extremely small compared to the risks and side effects.
Several medical research papers have concluded that most types of cancer do not respond positively to chemo or radiation therapies. Naturally, these papers receive little publicity, particularly compared to the “breakthrough” articles for research funded primarily by drug companies.
One such article is the 1992 paper by Dr. Ulrich Abel, a German biostatistician who spent 10 years as a statistician in clinical oncology. He found that:
“Apart from lung cancer, in particular small-cell lung cancer, there is no direct evidence that chemotherapy prolongs survival in patients with advanced carcinoma. Except for ovarian cancer, available indirect evidence rather supports the absence of a positive effect.
“In treatment of lung cancer and ovarian cancer, the therapeutic benefit is at best rather small, and a less aggressive treatment seems to be at least as effective as the usual one. It is possible that certain sub-groups of patients benefit from the treatment, yet so far the available results do not allow a sufficiently precise definition of these groups.
“Many oncologists take it for granted that response to therapy prolongs survival, an opinion which is based on a fallacy and which is not supported by clinical studies. To date, it is unclear whether the treated patients, as a whole, benefit from chemotherapy as to their quality of life.
“For most cancer sites, urgently required types of studies such as randomized de-escalations of dose or comparisons of immediate versus deferred chemotherapy are still lacking. With few exceptions, there is no good scientific basis for the application of chemotherapy in symptom-free patients with advanced epithelial malignancy.”
The actual report has been so well suppressed that it’s nearly impossible to locate. Yet, the interest in his findings has increased so much in recent years that the National Institutes of Health National Library of Medicine included a synopsis of his findings on its pubmed.gov site.
Naturally, I’m disappointed (but not surprised) that the e-mail stating a change of heart of Johns Hopkins wasn’t true.
But I’m hanging on to it. Someday, it will be true.












Recent Comments